Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Total Current Liabilities (2010 - 2026)

Geron's (GERN) quarterly Total Current Liabilities came in at $70.3 million in Q2 2026, up 9.41% year-over-year from $64.3 million in Q2 2025, and down 4.4% quarter-over-quarter from $73.6 million in Q1 2026.

Analysis

Geron (GERN) Total Current Liabilities (2010 - 2026) Analysis & Trends

Geron has disclosed Total Current Liabilities across 17 years of filings, most recently posting $70.3 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 9.41% year-over-year to $70.3 million; the TTM figure through Jun 2026 stood at $70.3 million (up 9.41% YoY), while the FY2025 annual figure was $111.5 million, up 26.32% from the prior year.
  • Total Current Liabilities came in at $70.3 million for Q2 2026 at Geron, down from $73.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $137.9 million in Q3 2024 to a low of $43.9 million in Q1 2023.
  • Average Total Current Liabilities over 5 years is $82.8 million, with a median of $79.8 million recorded in 2022.
  • Year-over-year, Total Current Liabilities soared 180.47% in 2024 and slumped 48.82% in 2025.
  • Over 5 years, Total Current Liabilities stood at $76.7 million in 2022, then soared by 40.91% to $108.1 million in 2023, then retreated by 18.3% to $88.3 million in 2024, then increased by 26.32% to $111.5 million in 2025, then slumped by 36.95% to $70.3 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $70.3 million in Q2 2026, $73.6 million in Q1 2026, and $111.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 Geron 914.60 Mn 613.75 Mn - 70.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.33 Mn
Mar 31, 2026 73.57 Mn
Dec 31, 2025 111.54 Mn
Sep 30, 2025 87.71 Mn
Jun 30, 2025 64.28 Mn
Mar 31, 2025 63.03 Mn
Dec 31, 2024 88.30 Mn
Sep 30, 2024 137.93 Mn
Jun 30, 2024 103.54 Mn
Mar 31, 2024 123.16 Mn
Dec 31, 2023 108.07 Mn
Sep 30, 2023 89.39 Mn
Jun 30, 2023 72.57 Mn
Mar 31, 2023 43.91 Mn
Dec 31, 2022 76.69 Mn
Sep 30, 2022 82.81 Mn
Jun 30, 2022 46.88 Mn
Mar 31, 2022 46.63 Mn
Dec 31, 2021 45.52 Mn
Sep 30, 2021 38.47 Mn